公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2018 | Pharmacokinetic study of bortezomib administered intravenously in Taiwanese patients with multiple myeloma | SHANG-YI HUANG ; Chang C.-S.; Liu T.-C.; Wang P.-N.; Yeh S.-P.; Ho C.-L.; Kuo M.-C.; Lin H.-Y.; de Jong J.; Chen J.-Y.; Yang Y.-W. | Hematological Oncology | 1 | 2 | |
2017 | Phase 2 study of tabalumab, a human anti-B-cell activating factor antibody, with bortezomib and dexamethasone in patients with previously treated multiple myeloma | Raje N.S.; Moreau P.; Terpos E.; Benboubker L.; Grząśko N.; Holstein S.A.; Oriol A.; SHANG-YI HUANG ; Beksac M.; Kuliczkowski K.; Tai D.F.; Wooldridge J.E.; Conti I.; Kaiser C.J.; Nguyen T.S.; Cronier D.M.; Palumbo A. | British Journal of Haematology | 38 | 33 | |
2021 | Pomalidomide and Dexamethasone Are Effective in Relapsed or Refractory Multiple Myeloma in a Real-Life Setting: A Multicenter Retrospective Study in Taiwan | Hung Y.-C.; Gau J.-P.; SHANG-YI HUANG ; BOR-SHENG KO ; Teng C.-L.J. | Frontiers in Oncology | 0 | 0 | |
2019 | Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)-a trial by the Asian Myeloma Network | Soekojo C.Y.; Kim K.; SHANG-YI HUANG ; Chim C.-S.; Takezako N.; Asaoku H.; Kimura H.; Kosugi H.; Sakamoto J.; Gopalakrishnan S.K.; Nagarajan C.; Wei Y.; Moorakonda R.; Lee S.L.; Lee J.J.; Yoon S.-S.; Kim J.S.; Min C.K.; Lee J.-H.; Durie B.; Chng W.J. | Blood Cancer Journal | 12 | 7 | |
2010 | Primary biliary cirrhosis associated with pernicious anemia | Chung C.-S.; Hsu Y.-C.; SHANG-YI HUANG ; YUNG-MING JENG ; CHIEN-HUNG CHEN | Canadian Family Physician | 6 | 5 | |
2011 | The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia | WEN-CHIEN CHOU ; Lei W.-C.; BOR-SHENG KO ; HSIN-AN HOU ; Chen C.-Y.; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Chang Y.-C.; KUAN-TING KUO ; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Leukemia | 132 | 132 | |
2017 | Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia | CHENG-HONG TSAI ; HSIN-AN HOU ; JIH-LUH TANG ; Kuo, Yuan-Yeh; Chiu, Yu-Chiao; CHIEN-CHIN LIN ; Liu, Chieh-Yu; Tseng, Mei-Hsuan; Lin, Tzung-Yi; Liu, Ming-Chih; Liu, Chia-Wen; LIANG-IN LIN ; MING YAO ; Li, Chi-Cheng; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; Lin, Chien-Ting; SHANG-JU WU ; Chen, Chien-Yuan ; WOEI TSAY ; ERIC YAO-YU CHUANG ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Blood Cancer Journal | 35 | 33 | |
2014 | Prognostic implication of gene mutations on overall survival in the adult acute myeloid leukemia patients receiving or not receiving allogeneic hematopoietic stem cell transplantations | SHENG-CHIEH CHOU ; JIH-LUH TANG ; HSIN-AN HOU ; WEN-CHIEN CHOU ; Hu F.-C.; Chen, Chien-Yuan ; MING YAO ; BOR-SHENG KO ; SHANG-YI HUANG ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Leukemia Research | 18 | 18 | |
2019 | Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma | Spicka I.; Ocio E.M.; Oakervee H.E.; Greil R.; Banh R.H.; SHANG-YI HUANG ; D'Rozario J.M.; Dimopoulos M.A.; Martínez S.; Extremera S.; Kahatt C.; Alfaro V.; Carella A.M.; Meuleman N.; Hájek R.; Symeonidis A.; Min C.-K.; Cannell P.; Ludwig H.; Sonneveld P.; Mateos M.V. | Annals of Hematology | 38 | 33 | |
2018 | Recent advances in the management of multiple myeloma: clinical impact based on resource-stratification. Consensus statement of the Asian Myeloma Network at the 16th international myeloma workshop | Tan D.; Lee J.H.; Chen W.; Shimizu K.; Hou J.; Suzuki K.; Nawarawong W.; SHANG-YI HUANG ; Sang Chim C.; Kim K.; Kumar L.; Malhotra P.; Chng W.J.; Durie B.; for the Asian Myeloma Network | Leukemia and Lymphoma | 16 | 13 | |
2016 | Reduced incidence of interstitial pneumonitis after Allogeneic hematopoietic stem cell transplantation using a modified technique of total body irradiation | YUN CHIANG ; CHENG-HONG TSAI ; SUNG-HSIN KUO ; Liu, Chieh-Yu; MING YAO ; Li, Chi-Cheng; SHANG-YI HUANG ; BOR-SHENG KO ; Lin, Chien-Ting; HSIN-AN HOU ; WEN-CHIEN CHOU ; JIA-HAU LIU ; CHIEN-CHIN LIN ; SHANG-JU WU ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Lin, Kai-Hsin; Lin, Dong-Tsamn; Chou, Hsien-Tang; Lu, Meng-Yu; YUNG-LI YANG ; HSIU-HAO CHANG ; Liu, Ming-Chih; Liao, Xiu-Wen; Wu, Jian-Kuen; SHENG-CHIEH CHOU ; Chieh-Lung Cheng ; Chen, Chien-Yuan ; WOEI TSAY ; HWEI-FANG TIEN ; JIH-LUH TANG ; YU-HSUAN CHEN | Scientific Reports | 18 | 15 | |
2003 | Reduction of leukocyte count is associated with thalidomide response in treatment of multiple myeloma | SHANG-YI HUANG ; JIH-LUH TANG ; MING YAO ; BOR-SHENG KO ; RUEY-LONG HONG ; Tsai W.; Wang C.-H.; HWEI-FANG TIEN ; MING-CHING SHEN ; YAO-CHANG CHEN | Annals of Hematology | 12 | 10 | |
2015 | Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults | Chieh-Lung Cheng ; Li, Chi-Cheng; HSIN-AN HOU ; Fang, Wei-Quan; Chang, Chin-Hao; Lin, Chien-Ting; JIH-LUH TANG ; WEN-CHIEN CHOU ; Chen, Chien-Yuan ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SHANG-JU WU ; WOEI TSAY ; HWEI-FANG TIEN | BMC cancer | 42 | 40 | |
2014 | SF3B1 mutations in patients with myelodysplastic syndromes: The mutation is stable during disease evolution | CHIEN-CHIN LIN ; HSIN-AN HOU ; WEN-CHIEN CHOU ; Kuo Y.-Y.; SHANG-JU WU ; Liu C.-Y.; Chen, Chien-Yuan ; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; SZU-CHUN HSU ; BOR-SHENG KO ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 30 | 26 | |
2016 | Soluble PD-L1: A biomarker to predict progression of autologous transplantation in patients with multiple myeloma | SHANG-YI HUANG ; Lin, Hsiu-Hsia; CHUNG-WU LIN ; Li, Chi-Cheng; MING YAO ; JIH-LUH TANG ; HSIN-AN HOU ; WOEI TSAY ; Chou, Sheng-Je; Chieh-Lung Cheng ; HWEI-FANG TIEN | Oncotarget | 26 | 26 | |
2016 | Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia | HSIN-AN HOU ; Liu, Chieh-Yu; Kuo, Yuan-Yeh; WEN-CHIEN CHOU ; CHENG-HONG TSAI ; CHIEN-CHIN LIN ; LIANG-IN LIN ; Tseng, Mei-Hsuan; Chiang, Ying-Chieh; Liu, Ming-Chih; Liu, Chia-Wen; JIH-LUH TANG ; MING YAO ; Li, Chi-Cheng; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; Chen, Chien-Yuan ; Lin, Chien-Ting; SHANG-JU WU ; WOEI TSAY ; HWEI-FANG TIEN | Oncotarget | 67 | 62 | |
2012 | A study of 46 patients with acquired haemophilia A in Taiwan finds elevated LDH level and mucosal bleedings associated with reduced response to immunosuppressive therapy | SHANG-YI HUANG ; WOEI TSAY ; Lin H.-Y.; SZU-CHUN HSU ; MING-CHING SHEN | Haemophilia | 2 | 2 | |
2015 | A study of 65 patients with acquired hemophilia A in Taiwan | SHANG-YI HUANG ; WOEI TSAY ; Lin S.-Y.; SZU-CHUN HSU ; Hung M.-H.; MING-CHING SHEN | Journal of the Formosan Medical Association | 23 | 22 | |
2019 | Survival differences in multiple myeloma in Latin America and Asia: a comparison involving 3664 patients from regional registries | Hungria V.T.M.; Lee J.H.; Maiolino A.; de Queiroz Crusoe E.; Martinez G.; Bittencourt R.; Duarte G.O.; Fantl D.B.; Navarro J.R.; Conte G.; Gomez-Almaguer D.; Ruiz-Argüelles G.J.; Kim K.; Shimizu K.; Chen W.; SHANG-YI HUANG ; Chng W.-J.; Chim C.S.; Nawarawong W.; Durie B. | Annals of Hematology | 9 | 6 | |
2021 | Survival, health care resource utilization and expenditures of first-line treatments for multiple myeloma patients ineligible for transplant in Taiwan | Cheng C.-N.; SHANG-YI HUANG ; Lien P.-W.; Huang S.-T.; FANG-JU LIN | PLoS ONE | 0 | 0 | |